130 related articles for article (PubMed ID: 93584)
1. Abortive expression of the Epstein-Barr virus (EBV) cycle in a variety of EBV DNA-containing cell lines, as reflected by nucleic acid hybridization in situ.
Moar MH; Klein G
Int J Cancer; 1979 Nov; 24(5):679-87. PubMed ID: 93584
[TBL] [Abstract][Full Text] [Related]
2. Somatic cell hybrids between human lymphoma cell lines. V. IdUrd inducibility and P3HR-1 superinfectability of Daudi/HeLa (DAD) and Daudi/P3HR-1 (DIP-1) cell lines.
Moar MH; Ber R; Klein G; Westman A; Eriksson I
Int J Cancer; 1978 Dec; 22(6):669-74. PubMed ID: 82545
[TBL] [Abstract][Full Text] [Related]
3. Effects of DNA synthesis inhibitors on early antigen expression following primary infection or superinfection by Epstein-Barr virus.
Lidin BI; Lamon EW
Arch Virol; 1983; 77(1):13-25. PubMed ID: 6312934
[TBL] [Abstract][Full Text] [Related]
4. Production of rabbit antibodies against the viral capsid antigen (VCA) of the Epstein-Barr virus (EBV).
Vestergaard BF; Hesse J; Norrild B; Klein G
Int J Cancer; 1978 Mar; 21(3):323-8. PubMed ID: 75856
[TBL] [Abstract][Full Text] [Related]
5. Detection localization of Epstein-Barr virus-associated early antigens in single cells by autoradiography using 125I-labeled antibodies. (With 1 color plate).
Moar MH; Siegert W; Klein G
Intervirology; 1977; 8(4):226-39. PubMed ID: 194866
[TBL] [Abstract][Full Text] [Related]
6. Autoradiographic detection of Epstein-Barr virus (EBV)-associated early antigen in a variety of EBV DNA-containing lymphoblastoid cell lines previously designated as nonproducers.
Moar MH; Siegert W; Klein G
Intervirology; 1978; 9(6):333-43. PubMed ID: 204604
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of Epstein-Barr virus derived from P3HR-1 cells.
zur Hausen H; Fresen KO
IARC Sci Publ (1971); 1978; (20):391-6. PubMed ID: 215522
[TBL] [Abstract][Full Text] [Related]
8. Somatic cell hybrids between human lymphoma lines. II. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle.
Klein G; Clements G; Zeuthen J; Westman A
Int J Cancer; 1976 Jun; 17(6):715-24. PubMed ID: 59708
[TBL] [Abstract][Full Text] [Related]
9. Multiplicity-dependent induction of viral capsid antigen in Raji cells superinfected with Epstein-Barr virus.
Fujiwara S; Takada K; Yano S; Osato T
Virology; 1983 Jul; 128(2):490-4. PubMed ID: 6310870
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus (P3HR-1) defective DNA codes for components of both the early antigen and viral capsid antigen complexes.
Cho MS; Gissmann L; Hayward SD
Virology; 1984 Aug; 137(1):9-19. PubMed ID: 6089423
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
Joncas JH; Wills A; Reece E; Fox Z
Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a second Epstein-Barr virus-determined nuclear antigen associated with the BamHI WYH region of EBV DNA.
Dillner J; Kallin B; Ehlin-Henriksson B; Timar L; Klein G
Int J Cancer; 1985 Mar; 35(3):359-66. PubMed ID: 2982749
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of Epstein-Barr virus originating from P3HR-1 cells. I. Studies on EBNA induction.
Fresen KO; Merkt B; Bornkamm GW; Hausen H
Int J Cancer; 1977 Mar; 19(3):317-23. PubMed ID: 191406
[TBL] [Abstract][Full Text] [Related]
14. Antigen-inducing ability of herpesvirus papio in human and baboon lymphoma lines, compared to Epstein-Barr virus.
Klein G; Falk L; Falk K
Intervirology; 1978; 10(3):153-64. PubMed ID: 210135
[TBL] [Abstract][Full Text] [Related]
15. Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains.
Fresen KO; Hausen H
Int J Cancer; 1976 Feb; 17(2):161-6. PubMed ID: 175026
[TBL] [Abstract][Full Text] [Related]
16. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
Fresen KO; zur Hausen H
Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of Epstein-Barr virus. IV. Induction of a specific antigen by EBV from two transformed marmoset cell lines in Ramos cells.
Fresen KO; Cho MS; zur Hausen H
Int J Cancer; 1978 Aug; 22(2):160-5. PubMed ID: 81181
[TBL] [Abstract][Full Text] [Related]
18. Hybridization between a human epithelial line, infectable by Epstein-Barr virus, and Burkitt lymphoma lines: membrane properties, superinfectability, inducibility and tumorigenicity.
Mitrani-Rosenbaum S; Ber R; Goldblum N; Povey S; Gamliel H; Ben-Bassat H
Int J Cancer; 1982 Nov; 30(5):593-600. PubMed ID: 6295967
[TBL] [Abstract][Full Text] [Related]
19. Esters of phosphonopropionic and phosphonoacetic acids: effect on synthesis of Epstein-Barr virus (EBV) antigens and on transformation of cord blood lymphocytes by EBV.
Margalith M; Manor D; Agranat I; Bentor Y; Gelfand T; Goldblum N
Cancer Biochem Biophys; 1980; 4(3):137-43. PubMed ID: 6254633
[TBL] [Abstract][Full Text] [Related]
20. Detection of antibodies to Epstein-Barr virus antigens by enzyme-linked immunosorbent assay.
Hopkins RF; Witmer TJ; Neubauer RH; Rabin H
J Infect Dis; 1982 Dec; 146(6):734-40. PubMed ID: 6183369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
